Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer

HER2 Heterogeneity Affects Trastuzumab Responses and Survival in Patients With HER2-Positive Metastatic Breast Cancer

(2014) Hee Jin Lee et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis

(2014) Ying Liu et al.   BMC CANCER

Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer

(2014) Hee Jin Lee et al.   BREAST CANCER RESEARCH AND TREATMENT

Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer

(2014) H J Lee et al.   BRITISH JOURNAL OF CANCER

Basal/HER2 breast carcinomas

(2013) Begoña Martin-Castillo et al.   CELL CYCLE

Spontaneous Epithelial-Mesenchymal Transition and Resistance to HER-2-Targeted Therapies in HER-2-Positive Luminal Breast Cancer

(2013) David Lesniak et al.   PLoS One

Prognostic Value of Basal Phenotype in HER2-overexpressing Breast Cancer

(2011) Sanjay P. Bagaria et al.   ANNALS OF SURGICAL ONCOLOGY

An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer

(2011) H E Lee et al.   BRITISH JOURNAL OF CANCER

Dynamic emergence of the mesenchymal CD44posCD24neg/low phenotype in HER2-gene amplified breast cancer cells with de novo resistance to trastuzumab (Herceptin)

(2010) Cristina Oliveras-Ferraros et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures

(2010) Liheng Zhou et al.   BREAST CANCER RESEARCH AND TREATMENT

Mechanisms of resistance to anti-human epidermal growth factor receptor 2 agents in breast cancer

(2010) Toru Mukohara   CANCER SCIENCE

Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer

(2010) S. Y. Park et al.   CLINICAL CANCER RESEARCH

Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer

(2009) H Nalwoga et al.   BRITISH JOURNAL OF CANCER

Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers

(2009) T. Tanei et al.   CLINICAL CANCER RESEARCH

Stemming Resistance to HER-2 Targeted Therapy

(2009) Philippe L. Bedard et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

(2008) Sendurai A. Mani et al.   CELL

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Implications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and Therapy

(2008) Madhuri Kakarala et al.   JOURNAL OF CLINICAL ONCOLOGY

Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers

(2008) Stephen Chia et al.   JOURNAL OF CLINICAL ONCOLOGY

Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy

(2008) X. Li et al.   JNCI-Journal of the National Cancer Institute

HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion

(2008) H Korkaya et al.   ONCOGENE